Title: Strategic Analysis on World Congestive Heart Failure (CHF) Treatment Devices Market 2022
1World Congestive Heart Failure (CHF) Treatment
Devices Market - Opportunities and Forecasts,
2015 - 2022
Published Date 01 May, 2016 No of Pages
135 Single User Price 4740
World CHF Treatment Devices Market is estimated
to reach 14,823.3 million by 2022
Click Here To Check Complete Report
2- Congestive heart failure (CHF) is a physiological
condition that has an adverse impact on the
pumping efficiency of the cardiac muscles. - It characterizes the accumulation of fluid around
the heart leading to inefficient pumping. - The onset of CHF is marked by the failure of the
ventricles to pump sufficient volume of blood to
the body organs. - This eventually leads to deposition of fluid in
the lungs, abdomen, liver, and lower body. - CHF is treated by a number of devices that
maintain heart rhythm, such as pacemakers,
cardiac resynchronization therapy (CRT),
implantable cardioverter defibrillators (ICDs),
and ventricular assist devices (VADs). - The world CHF treatment devices market was
evaluated at 10,127.2 million in 2015, and is
estimated to reach 14,823.3 million by 2022,
with a CAGR of 5.5 over the forecast period. - This is primarily attributed to the constantly
changing lifestyle habits (such as unhealthy
dietary habits, excessive alcohol consumption,
smoking, obesity, and lack of physical activity)
which make individuals more susceptible to
arrhythmia and heart failure.
3- In addition, a number of factors such as the
large number of technological advancements in CHF
treatment devices, increased adoption rate of
these devices, and rising emphasis on early
intervention and primary prevention of
heart-related disorders are responsible for
driving the market. - Conversely, stringent government regulations for
the approval of CHF treatment devices, high cost
of, and high preference to drugs for CHF
treatment are some of the factors restraining the
market growth. - The report segments the world CHF treatment
devices market based on product type, namely,
pacemakers, cardiac resynchronization therapy
(CRT) devices, implantable cardioverter
defibrillators (ICDs), and ventricular assist
devices (VADs). - Pacemaker is further segmented into dual-chamber
pacemakers and single-chamber pacemakers. - CRT devices is segmented into two major types,
namely, CRT-P and CRT-D. ICDs is further
segmented into transvenous implantable
cardioverter defibrillator (T-ICDs) and
subcutaneous implantable cardioverter
defibrillator (S-ICDs). - VADs is also segmented into left ventricular
assist device (LVAD), right ventricular assist
device (RVAD), and biventricular assist device
(BIVAD).
4- ICDs was the highest revenue-generating segment
in 2015, owing to the stressful hyperactive
lifestyle, unhealthy food habits, and growing
number of aging population. - Based on geography, the market is divided into
North America, Europe, Asia-Pacific, and LAMEA
regions. - The key players in this market adopted product
development and product launch as their key
strategies to keep pace with the changing demands
of consumers. - Furthermore, companies launched cost-effective
and technologically efficient products to
strengthen their market position. - The report provides a comprehensive analysis of
the key players operating in the world CHF
treatment devices market, such as Abiomed, Inc.,
Berlin Heart GmbH, Biotronik SE Co. KG, Boston
Scientific Corporation, HeartWare International,
Inc., Jarvik Heart, Inc., LivaNova PLC, Medtronic
plc, ReliantHeart Inc., and St. Jude Medical,
Inc. - Key Benefits The study provides an in-depth
analysis of the world CHF treatment devices
market with current trends and future estimations
to elucidate the imminent investment pockets in
the market.
Make an Inquiry Before Buying
5- The report provides a comprehensive analysis of
the key players operating in the world CHF
treatment devices market, such as Abiomed, Inc.,
Berlin Heart GmbH, Biotronik SE Co. KG, Boston
Scientific Corporation, HeartWare International,
Inc., Jarvik Heart, Inc., LivaNova PLC, Medtronic
plc, ReliantHeart Inc., and St. Jude Medical,
Inc. - Key Benefits The study provides an in-depth
analysis of the world CHF treatment devices
market with current trends and future estimations
to elucidate the imminent investment pockets in
the market. - The report provides a quantitative analysis from
2015 to 2022 that would enable the stakeholders
to capitalize on prevailing market opportunities.
- Extensive analysis of the world CHF treatment
devices market, by product, helps in
understanding the various types of devices used
for the treatment of CHF and other related
cardiac conditions. - Competitive intelligence highlights the business
practices followed by leading market players
across various geographic regions.
Download Sample Brochure
6- SWOT analysis enables to study the internal
environment of the leading companies for strategy
formulation. - CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES
MARKET KEY SEGMENTS Congestive Heart Failure
(CHF) Treatment Devices Market, - By Product Pacemakers,
- By Type Implantable Pacemakers External
Pacemakers Cardiac Resynchronization Therapy
(CRT), By Type Cardiac Resynchronization
Therapy-Pacemakers (CRT-P)Cardiac
Resynchronization Therapy-Defibrillators
(CRT-D)Implantable Cardioverter Defibrillators
(ICDs), - By TypeTransvenous Implantable Cardioverter
Defibrillator (T-ICDs)Subcutaneous Implantable
Cardioverter Defibrillator (S-ICDs)Ventricular
Assist Devices (VADs), - By Type Left Ventricular Assist Device
(LVAD)Right Ventricular Assist Device
(RVAD)Biventricular Assist Device (BIVAD) - By Geography North AmericaU.S.CanadaMexicoEuropeGe
rmanyU.K.FranceRest of EuropeAsia-PacificJapanChin
aIndiaRest of Asia-PacificLAMEALatin
AmericaMiddle EastAfrica
7World Congestive Heart Failure (CHF) Treatment
Devices Market - Opportunities and Forecasts,
2015 - 2022
A detailed qualitative analysis of the factors
responsible for driving and restraining growth of
the World Congestive Heart Failure (CHF)
Treatment Devices Market and future opportunities
are provided in the report.
Contact 1-302-261-5343 sales_at_marketintelreports.
com www.marketintelreports.com
Click here to order a copy of World Congestive
Heart Failure (CHF) Treatment Devices Market
Report